About Alisha O'Dell
Form D filings for Gerosynth Laboratories from 2022 to 2024 list Alisha O'Dell as CEO and director.
Alisha O'Dell first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Alisha O'Dell in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Alisha O'Dell works with at each company, as listed on that company's latest Form D.
Gerosynth Laboratories, Inc. · Form D, Dec 12, 2024
EC
Erin Clark
Executive officer and director
BH
Brian Hatlevig
Director
BP
Bethany Pope
Executive officer and director